Literature DB >> 15816377

Endocrine disturbances in depression.

M A Tichomirowa1, M E Keck, H J Schneider, M Paez-Pereda, U Renner, F Holsboer, G K Stalla.   

Abstract

Depression is one of the most common psychiatric disorders. For a long time, clinicians suspected a causal link between depression and the endocrine system. The most frequently occurring endocrine abnormality in depressed subjects is hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis. CRH and AVP are likely to play a substantial role in the pathophysiology of this disorder, and their receptors appear to be a specific target for future antidepressant drugs. Depression also affects the hypothalamic-pituitary-GH (HPGH) and -thyroid (HPT) axes. Alterations in the reproductive system may also play a role in the pathology of depression. In addition, there is increasing evidence that leptin and neurosteroids, such as DHEA, are implicated in mood disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15816377     DOI: 10.1007/bf03345535

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  145 in total

Review 1.  The corticosteroid receptor hypothesis of depression.

Authors:  F Holsboer
Journal:  Neuropsychopharmacology       Date:  2000-11       Impact factor: 7.853

2.  Pulsatile rhythms of adrenocorticotropin (ACTH) and cortisol in women with endogenous depression: evidence for increased ACTH pulse frequency.

Authors:  J F Mortola; J H Liu; J C Gillin; D D Rasmussen; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1987-11       Impact factor: 5.958

3.  Double-blind treatment of major depression with dehydroepiandrosterone.

Authors:  O M Wolkowitz; V I Reus; A Keebler; N Nelson; M Friedland; L Brizendine; E Roberts
Journal:  Am J Psychiatry       Date:  1999-04       Impact factor: 18.112

4.  Endogenous concentrations of DHEA and DHEA-S decrease with remission of depression in older adults.

Authors:  T J Fabian; M A Dew; B G Pollock; C F Reynolds; B H Mulsant; M A Butters; M D Zmuda; A M Linares; M Trottini; P D Kroboth
Journal:  Biol Psychiatry       Date:  2001-11-15       Impact factor: 13.382

5.  V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats.

Authors:  R Landgraf; R Gerstberger; A Montkowski; J C Probst; C T Wotjak; F Holsboer; M Engelmann
Journal:  J Neurosci       Date:  1995-06       Impact factor: 6.167

6.  CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.

Authors:  S E Molchan; B A Lawlor; J L Hill; R A Martinez; C L Davis; A M Mellow; D R Rubinow; T Sunderland
Journal:  Biol Psychiatry       Date:  1991-06-01       Impact factor: 13.382

Review 7.  Vasopressin as a target for antidepressant development: an assessment of the available evidence.

Authors:  Lucinda V Scott; Timothy G Dinan
Journal:  J Affect Disord       Date:  2002-11       Impact factor: 4.839

8.  Immunocytochemical evidence for direct synaptic connections between corticotrophin-releasing factor (CRF) and gonadotrophin-releasing hormone (GnRH)-containing neurons in the preoptic area of the rat.

Authors:  N J MacLusky; F Naftolin; C Leranth
Journal:  Brain Res       Date:  1988-01-26       Impact factor: 3.252

Review 9.  Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties.

Authors:  R Rupprecht
Journal:  Psychoneuroendocrinology       Date:  2003-02       Impact factor: 4.905

10.  Influence of human corticotropin-releasing hormone and adrenocorticotropin upon spontaneous growth hormone secretion.

Authors:  K Wiedemann; U von Bardeleben; F Holsboer
Journal:  Neuroendocrinology       Date:  1991-11       Impact factor: 4.914

View more
  25 in total

1.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

2.  Modulation of central glucocorticoid receptors in short- and long-term experimental hyperthyroidism.

Authors:  Elena Nikolopoulou; Dimitrios Mytilinaios; Aldo E Calogero; Themis C Kamilaris; Theodore Troupis; George P Chrousos; Elizabeth O Johnson
Journal:  Endocrine       Date:  2015-02-27       Impact factor: 3.633

Review 3.  Control of ACTH secretion by excitatory amino acids: functional significance and clinical implications.

Authors:  Daniela Jezova
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

4.  Hypoxic preconditioning prevents development of post-stress depressions in rats.

Authors:  E A Rybnikova; V I Mironova; S G Pivina; N E Ordyan; E I Tyulkova; M O Samoilov
Journal:  Dokl Biol Sci       Date:  2006 Nov-Dec

Review 5.  The role of corticotropin-releasing factor and noradrenaline in stress-related responses, and the inter-relationships between the two systems.

Authors:  Adrian J Dunn; Artur H Swiergiel
Journal:  Eur J Pharmacol       Date:  2008-01-26       Impact factor: 4.432

6.  Synthesis and evaluation of potent and selective human V1a receptor antagonists as potential ligands for PET or SPECT imaging.

Authors:  Karine Fabio; Christophe Guillon; Carl J Lacey; Shi-fang Lu; Ned D Heindel; Craig F Ferris; Michael Placzek; Graham Jones; Michael J Brownstein; Neal G Simon
Journal:  Bioorg Med Chem       Date:  2011-12-20       Impact factor: 3.641

7.  gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression.

Authors:  Qiuying Shen; Rachnanjali Lal; Beth A Luellen; John C Earnheart; Anne Milasincic Andrews; Bernhard Luscher
Journal:  Biol Psychiatry       Date:  2010-07-01       Impact factor: 13.382

Review 8.  Harmful effects of functional hypercortisolism: a working hypothesis.

Authors:  Giacomo Tirabassi; Marco Boscaro; Giorgio Arnaldi
Journal:  Endocrine       Date:  2013-11-27       Impact factor: 3.633

9.  The diagnosis of depression: current and emerging methods.

Authors:  Katie M Smith; Perry F Renshaw; John Bilello
Journal:  Compr Psychiatry       Date:  2012-08-15       Impact factor: 3.735

10.  The possible use of hypoxic preconditioning for the prophylaxis of post-stress depressive episodes.

Authors:  E A Rybnikova; M O Samoilov; V I Mironova; E I Tyul'kova; S G Pivina; L A Vataeva; N E Ordyan; E Yu Abritalin; A I Kolchev
Journal:  Neurosci Behav Physiol       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.